Last updated: February 19, 2019
Sponsor: Campbell Grant
Overall Status: Terminated
Phase
4
Condition
Overactive Bladder
Enuresis
Treatment
N/AClinical Study ID
NCT02865395
GW051534
Ages 18-89 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients undergoing lithotripsy procedure at GW Hospital
Exclusion
Exclusion Criteria:
- The criteria for exclusion for those patients who agree to participate in the studywill be patients with glaucoma, severe hepatic or renal disease, bronchial asthma,respiratory depression at the time of administration, convulsive disorders, allergy toanti-muscarinics or opiates, history of anorectal surgery, pre-operative use ofantimuscarinics, chronic pain, chronic use of analgesics, or a history of alcohol oropioid dependency.
Study Design
Total Participants: 23
Study Start date:
March 01, 2016
Estimated Completion Date:
June 30, 2017
Study Description
Connect with a study center
George Washington University
Washington, District of Columbia 20037
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.